Osteoclastogenesis by bone marrow-derived macrophages is enhanced in obese mice

Journal of Nutrition

Volumn 139, Issue 3, 2009, Pages 502-506

  Kyung, Tae Wook ^a   Lee, Ji Eun ^a   Van Phan, Tien ^a   Yu, Rina ^b   Choi, Hye Seon ^b  

^a Immunomodulation Research Center   (South Korea)

^b University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL MODEL; BONE DENSITY; BONE DEVELOPMENT; BONE MARROW; CELL DIFFERENTIATION; CELL GROWTH; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET; FEMUR; GROWTH INHIBITION; LEAN BODY WEIGHT; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; OSSIFICATION; OSTEOCLAST; ANIMAL; ARTICLE; C57BL MOUSE; DRUG EFFECT; FAT INTAKE; GERMFREE ANIMAL; METABOLISM; OSTEOLYSIS; PHYSIOLOGY;

MUS;

ANIMALS; BONE DENSITY; BONE RESORPTION; DIETARY FATS; INTERLEUKIN-10; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; OBESITY; OSTEOCLASTS; RANK LIGAND; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 62749120123     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.108.100032     Document Type: Conference Paper

References (34)

1. Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res. 1993;8:567-73.
2. Reid IR. Relationships among body mass, its components, and bone. Bone. 2002;31:547-55.
3. Wang MC, Bachrach LK, Van Loan M, Hudes M, Flegal KM, Crawford PB. The relative contributions of lean tissue mass and fat mass to bone density in young women. Bone. 2005;37:474-81.
4. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000;100: 197-207.
5. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest. 2004;113:846-55.
6. Takeda T, Matsushita T, Kurozumi M, Takemura K, Higuchi K, Hosokawa M. Pathobiology of the senescence-accelerated mouse (SAM). Exp Gerontol. 1997;32:117-27.
7. Kodama Y, Takeuchi Y, Suzuwa M, Fukumoto S, Murayama H, Yamato H, Fujita T, Kurokawa T, Matsumoto T. Reduced expression of interleukin-11 in bone marrow stromal cells of senescence-accelerated mice (SAMP6): relationship to osteopenia with enhanced adipogenesis. J Bone Miner Res. 1998;13:1370-7.
8. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999;20:345-57.
9. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos Santos AJ, Van G, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397:315-23.
10. Horowitz MC, Xi Y, Wilson K, Kacena MA. Control of osteoclasto genesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev. 2001;12:9-18.
11. de Vries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med. 1995;27:537-41.
12. Xu LX, Kukita T, Kukita A, Otsuka T, Niho Y, Iijima T. Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system. J Cell Physiol. 1995;165:624-9.
13. Sasaki H, Hou L, Belani A, Wang CY, Uchiyama T, Muller R, Stashenko P. IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J Immunol. 2000;165:3626-30.
14. Shin HH, Lee JE, Lee EA, Kwon BS, Choi HS. Enhanced osteoclasto genesis in 4-lBB-deficient mice caused by reduced interleukin-10. J Bone Miner Res. 2006;21:1907-12.
15. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409-15.
16. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest. 1996;97:1111-6.
17. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-9.
18. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17: 4-12.
19. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5:953-64.
20. Roodman GD. Advances in bone biology: the osteoclast. Endocr Rev. 1996;17:308-32.
21. Jansson JO, Moverare-Skrtic S, Berndtsson A, Wernstedt I, Carlsten H, Ohlsson C. Leukaemia inhibitory factor reduces body fat mass in ovariectomized mice. Eur J Endocrinol. 2006;154:349-54.
22. Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol. 1999;163:434-42.
23. Ammann P, Rizzoli R, Slosman D, Bonjour JP. Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometry. J Bone Miner Res. 1992;7:311-6.
24. Griffin MG, Kimble R, Hopfer W, Pacifici R. Dual-energy x-ray absorptiometry of the rat: accuracy, precision, and measurement of bone loss. J Bone Miner Res. 1993;8:795-800.
25. Amar S, Zhou Q, Shaik-Dasthagirisaheb Y, Leeman S. Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci USA. 2007;104: 20466-71.
26. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol. 2006;2:35-43.
27. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. Tumor necrosis factor-alpha induces differentiation and bone resorption by osteoclasts. J Biol Chem. 2000;275:4858-64.
28. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-808.
29. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol. 2005;25:2062-8.
30. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117:175-84.
31. Al-Rasheed A, Scheerens H, Srivastava AK, Rennick DM, Tatakis DN. Accelerated alveolar bone loss in mice lacking interleukin-10: late onset. J Periodontal Res. 2004;39:194-8.
32. Cohen SL, Moore AM, Ward WE. Interleukin-10 knockout mouse: a model for studying bone metabolism during intestinal inflammation. Inflamm Bowel Dis. 2004;10:557-63.
33. Carmody EE, Schwarz EM, Puzas JE, Rosier RN, O'Keefe RJ. Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Arthritis Rheum. 2002;46:1298-308.
34. Zhang X, Teng YT. Interleukin-10 inhibits gram-negative-microbespecific human receptor activator of NF-kappaB ligand-positive CD4+-Th1-cell-associated alveolar bone loss in vivo. Infect Immun. 2006;74: 4927-31.